Lineage Cell Therapeutics Inc (LCTX)
1.11
+0.01
(+0.91%)
USD |
NYAM |
Apr 25, 16:00
1.17
+0.06
(+5.41%)
After-Hours: 20:00
Lineage Cell Therapeutics Free Cash Flow (Quarterly): -6.11M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.11M |
| September 30, 2023 | -5.176M |
| June 30, 2023 | -6.524M |
| March 31, 2023 | -11.43M |
| December 31, 2022 | -8.287M |
| September 30, 2022 | -5.766M |
| June 30, 2022 | -7.159M |
| March 31, 2022 | 21.86M |
| December 31, 2021 | -6.019M |
| September 30, 2021 | -4.916M |
| June 30, 2021 | -5.531M |
| March 31, 2021 | -7.435M |
| December 31, 2020 | -5.665M |
| September 30, 2020 | -4.871M |
| June 30, 2020 | -4.245M |
| March 31, 2020 | -5.036M |
| December 31, 2019 | -5.53M |
| September 30, 2019 | -7.512M |
| June 30, 2019 | -9.862M |
| March 31, 2019 | -9.483M |
| December 31, 2018 | -6.828M |
| September 30, 2018 | -8.566M |
| June 30, 2018 | -7.439M |
| March 31, 2018 | -11.34M |
| December 31, 2017 | -6.071M |
| Date | Value |
|---|---|
| September 30, 2017 | -8.137M |
| June 30, 2017 | -9.322M |
| March 31, 2017 | -8.313M |
| December 31, 2016 | -9.24M |
| September 30, 2016 | -9.391M |
| June 30, 2016 | -11.06M |
| March 31, 2016 | -15.16M |
| December 31, 2015 | -14.94M |
| September 30, 2015 | -13.08M |
| June 30, 2015 | -12.42M |
| March 31, 2015 | -9.442M |
| December 31, 2014 | -9.315M |
| September 30, 2014 | -8.701M |
| June 30, 2014 | -10.95M |
| March 31, 2014 | -10.59M |
| December 31, 2013 | -8.928M |
| September 30, 2013 | -7.657M |
| June 30, 2013 | -7.683M |
| March 31, 2013 | -7.518M |
| December 31, 2012 | -5.192M |
| September 30, 2012 | -5.060M |
| June 30, 2012 | -3.995M |
| March 31, 2012 | -5.834M |
| December 31, 2011 | -4.025M |
| September 30, 2011 | -3.838M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-11.43M
Minimum
Mar 2023
21.86M
Maximum
Mar 2022
-5.011M
Average
-5.766M
Median
Sep 2022
Free Cash Flow (Quarterly) Benchmarks
| Acumen Pharmaceuticals Inc | -8.328M |
| Sarepta Therapeutics Inc | -73.70M |
| CEL-SCI Corp | -4.953M |
| AIM ImmunoTech Inc | -9.956M |
| IGC Pharma Inc | -1.674M |